Medincell Expands Dr Grace Kim's Role to Boost US Capital Growth

Medincell, a clinical-stage pharmaceutical company in Montpellier, France, has announced an expanded role for Dr. Grace Kim as Chief Strategy Officer, U.S. Finance, to further its US capital growth strategy. Dr. Kim has been instrumental over the past two years in shaping the company's strategy and advancing cross-border initiatives.

As Medincell enters a key growth phase, Dr. Kim will lead the next stages of the company’s US capital growth, enhancing long-term value for patients, partners, and investors. Her previous roles include positions at Molecular Templates and SNO Bio, alongside a successful advisory career, marking her as a leader in the field with a notable track record.